PALI

PALI

USD

Palisade Bio Inc. Common Stock

$1.855-0.055 (-2.880%)

实时价格

Healthcare
生物技术
美国

价格图表

Loading Chart...

关键指标

市场指标
公司基本面
交易统计

市场指标

开盘价

$1.910

最高价

$1.970

最低价

$1.822

成交量

1.22M

公司基本面

市值

259.3M

所属行业

生物技术

国家/地区

United States

交易统计

平均成交量

8.45M

交易所

NCM

货币

USD

52周价格范围

最低价 $0.53当前价 $1.855最高价 $3.3

相关新闻

GlobeNewswire

Palisade Bio Appoints Sharon Skare as Vice President, Global Head of Clinical Operations

Seasoned Pharmaceutical leader bringing over 24 years of experience in clinical development across autoimmune, metabolic, cardiovascular, and gastrointestinal indications Company remains focused on advancing PALI-2108

查看更多
Palisade Bio Appoints Sharon Skare as Vice President, Global Head of Clinical Operations
GlobeNewswire

Palisade Bio Granted Canadian Patent Covering Composition of Lead Product Candidate PALI-2108

PALI-2108 is the first and only PDE4 inhibitor designed to target terminal ileum and colon for fibrostenotic Crohn's disease (FSCD) and ulcerative colitis (UC) to address significant unmet medical needs Carlsbad, CA,

查看更多
Palisade Bio Granted Canadian Patent Covering Composition of Lead Product Candidate PALI-2108
GlobeNewswire

Palisade Bio Announces Cancellation of Special Meeting of Stockholders

Carlsbad, CA, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (NASDAQ:PALI) ("Palisade", "Palisade Bio", or the "Company"), a clinical-stage biopharmaceutical company advancing novel therapeutics for patients

查看更多
Palisade Bio Announces Cancellation of Special Meeting of Stockholders